Equities analysts predict that Sapiens International Co. (NASDAQ:SPNS) will report sales of $70.63 million for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Sapiens International’s earnings, with the lowest sales estimate coming in at $70.06 million and the highest estimate coming in at $71.20 million. Sapiens International posted sales of $69.05 million in the same quarter last year, which suggests a positive year over year growth rate of 2.3%. The firm is expected to report its next earnings results on Monday, August 6th.
According to Zacks, analysts expect that Sapiens International will report full-year sales of $284.81 million for the current fiscal year, with estimates ranging from $284.61 million to $285.00 million. For the next year, analysts forecast that the business will post sales of $299.20 million per share. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Sapiens International.
Sapiens International (NASDAQ:SPNS) last posted its quarterly earnings results on Monday, May 7th. The technology company reported $0.13 EPS for the quarter, topping the Zacks’ consensus estimate of $0.09 by $0.04. The company had revenue of $71.09 million for the quarter, compared to analysts’ expectations of $67.68 million. Sapiens International had a return on equity of 9.22% and a net margin of 1.90%. The firm’s revenue was up 25.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.02 EPS.
Several analysts have recently issued reports on SPNS shares. BidaskClub cut Sapiens International from a “hold” rating to a “sell” rating in a report on Saturday, March 17th. Zacks Investment Research raised Sapiens International from a “sell” rating to a “hold” rating in a report on Tuesday, April 17th. William Blair cut Sapiens International from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 8th. Finally, ValuEngine cut Sapiens International from a “hold” rating to a “sell” rating in a report on Saturday, June 2nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. Sapiens International has a consensus rating of “Hold” and a consensus price target of $12.50.
Shares of SPNS opened at $10.16 on Friday. The company has a market cap of $483.36 million, a PE ratio of 37.93, a PEG ratio of 4.18 and a beta of 1.29. Sapiens International has a 1 year low of $8.01 and a 1 year high of $14.30. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.46 and a current ratio of 1.46.
Several institutional investors and hedge funds have recently modified their holdings of the company. Meitav Dash Investments Ltd. bought a new position in shares of Sapiens International during the 4th quarter valued at approximately $554,000. Clal Insurance Enterprises Holdings Ltd increased its position in shares of Sapiens International by 135.1% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 803,583 shares of the technology company’s stock valued at $6,855,000 after purchasing an additional 461,710 shares during the last quarter. UBS Group AG increased its position in shares of Sapiens International by 114.4% during the 1st quarter. UBS Group AG now owns 86,524 shares of the technology company’s stock valued at $739,000 after purchasing an additional 46,171 shares during the last quarter. Finally, Jane Street Group LLC increased its position in shares of Sapiens International by 105.5% during the 1st quarter. Jane Street Group LLC now owns 31,988 shares of the technology company’s stock valued at $273,000 after purchasing an additional 16,420 shares during the last quarter. 9.26% of the stock is currently owned by institutional investors and hedge funds.
About Sapiens International
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers software platform and solutions for life, pension, and annuities, such as Sapiens ALIS, LifeSuite, Life Portraits, LifeApply, Sapiens INSIGHT, and Sapiens Closed Books; and personal, commercial and specialty lines, and workers' compensation comprising Sapiens IDIT, Adaptik Policy, Adaptik Billing, Stream Claim, Sapiens Stingray, PowerSuite, and CompSuite.
Get a free copy of the Zacks research report on Sapiens International (SPNS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.